Ana
Moreno Álvarez
Publicacións (21) Publicacións de Ana Moreno Álvarez
2024
-
Biomarcadores séricos para la evaluación de la fibrosis hepática
Advances in Laboratory Medicine, Vol. 5, Núm. 2, pp. 131-147
-
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment
Biomedicine and Pharmacotherapy, Vol. 173
-
Erratum: Correction to: Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP (European journal of pediatrics (2024) 183 8 DOI: 10.1007/s00431-024-05575-7)
European journal of pediatrics
-
Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials
Children, Vol. 11, Núm. 3
-
Serum biomarkers for liver fibrosis assessment
Advances in Laboratory Medicine, Vol. 5, Núm. 2, pp. 115-130
-
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP
European Journal of Pediatrics, Vol. 183, Núm. 8, pp. 3417-3430
2023
-
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research
-
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research, Vol. 194
2022
-
Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years
Eurosurveillance, Vol. 27, Núm. 19
-
Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial
Nutrients, Vol. 14, Núm. 3
-
Neonatal diabetes onset mimicking an organic acidemia
Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 2, pp. 149-150
-
The Role of Partial Enteral Nutrition for Induction of Remission in Crohn’s Disease: A Systematic Review of Controlled Trials
Nutrients, Vol. 14, Núm. 24
2021
-
Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease
British Journal of Clinical Pharmacology, Vol. 87, Núm. 2, pp. 447-457
-
Whole transcription profile of responders to anti-tnf drugs in pediatric inflammatory bowel disease
Pharmaceutics, Vol. 13, Núm. 1, pp. 1-17
2020
-
Gene signatures of early response to anti-TNF drugs in pediatric inflammatory bowel disease
International Journal of Molecular Sciences, Vol. 21, Núm. 9
-
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease
Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515
-
Primary cricopharyngeal achalasia
Anales de Pediatria, Vol. 92, Núm. 4, pp. 243-244
2019
-
Fructose malabsorption in asymptomatic children and in patients with functional chronic abdominal pain: a prospective comparative study
European Journal of Pediatrics, Vol. 178, Núm. 9, pp. 1395-1403
2018
-
V232D mutation in patients with cystic fibrosis Not so rare, not so mild
Medicine (United States), Vol. 97, Núm. 28